Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study

被引:21
|
作者
Zhang, XY
Zhou, DF
Cao, LY
Zhang, PY
Wu, GY
Shen, YC
机构
[1] Yale Univ, Sch Med, Connecticut Mental Hlth Ctr, Abraham Ribicoff Res Facil, New Haven, CT 06508 USA
[2] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China
[3] Beijing Hui Long Guan Hosp, Beijing, Peoples R China
关键词
schizophrenia; prolactin; antipsychotic drug; dopamine; risperidone; haloperidol; double-blind; symptom; outcome;
D O I
10.1007/s00213-004-1975-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: There are few data from systematic, double-blind clinical trials that have compared the effect of the typical and the atypical antipsychotics on serum prolactin (PRL) levels in patients with schizophrenia. Objectives: The goal of this study was to compare the effect of risperidone and haloperidol on serum PRL and investigate the relationship between serum PRL levels and clinical response in patients with schizophrenia. Methods: Seventy-eight inpatients with a diagnosis of schizophrenia (according to DSM-III-R) were randomly assigned to 12 weeks of treatment with 6 mg/day of risperidone or 20 mg/day of haloperidol after a 2-week washout period, using a randomized, double-blind design. Clinical efficacy was determined using the positive and negative syndrome scale (PANSS). Their serum PRL was assayed by means of radioimmunometric assay (RIA) between pre-treatment and post-treatment, and compared with 30 sex-matched and age-matched normal subjects. Results: Both risperidone and haloperidol treatment significantly increased serum PRL levels in drug-free chronic schizophrenia patients (both P<0.001). Hyperprolactinemia induced by risperidone 6 mg/kg was comparable to levels produced by haloperidol 20 mg/day. Considering dose-adjusted serum PRL levels, risperidone treatment induced a significant elevation of PRL levels compared with haloperidol treatment at the haloperidol equivalent (P<0.001). Change in PRL levels at pre-treatment and post-treatment were related to positive symptom improvement seen in the risperidone group (r=0.51, P=0.016), but not in the haloperidol group (P>0.05). Female patients showed both a higher baseline and post-treatment PRL level and a greater increase in PRL than men (all P<0.05). Conclusions: Risperidone is associated with a robust effect on prolactin secretion in contrast to the conventional antipsychotic haloperidol. Prolactin monitoring during risperidone treatment should be performed.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 50 条
  • [1] Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study
    Xiang Yang Zhang
    Dong Feng Zhou
    Lian Yuan Cao
    Pei Yan Zhang
    Gui Ying Wu
    Yu Cun Shen
    [J]. Psychopharmacology, 2005, 178 : 35 - 40
  • [2] A prospective, randomized, double-blind study examining functioning in schizophrenic patients treated with olanzapine and risperidone
    Dolnak, DR
    Rapaport, MH
    [J]. SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 225 - 226
  • [3] Elementary cognitive subprocesses in a double-blind study of haloperidol and risperidone in subchronic schizophrenic patients
    Ulferts, J
    Hagenhoff, M
    Krieger, S
    Gallhofer, B
    [J]. PHARMACOPSYCHIATRY, 2003, 36 (05) : 269 - 269
  • [4] DOUBLE-BLIND COMPARISON OF RISPERIDONE AND HALOPERIDOL IN SCHIZOPHRENIC AND SCHIZOAFFECTIVE PSYCHOSES
    CESKOVA, E
    SVESTKA, J
    [J]. PHARMACOPSYCHIATRY, 1993, 26 (04) : 121 - 124
  • [5] The interaction between superoxide dismutase and prolactin is involved in response to haloperidol and risperidone treatment in schizophrenia - A double-blind and randomized study
    Zhang, XY
    Zhou, DF
    Cao, LY
    Wu, GY
    Shen, YC
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (01) : 103 - 105
  • [6] A randomized, double-blind, comparison of risperidone versus risperidone plus haloperidol treatment in schizophrenia
    Lin, C. H.
    Kuo, C. C.
    Chou, L. S.
    Wang, S. J.
    Chen, M. C.
    Chen, C. C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S256 - S256
  • [7] Randomized study of haloperidol and risperidone on emotional reactions in schizophrenic patients
    Fakra, E
    Azorin, J
    Bouhours, P
    Blin, O
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S398 - S398
  • [8] Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients
    Esel, E
    Basturk, M
    Gonul, AS
    Kula, M
    Turan, MT
    Yabanoglu, I
    Sofuoglu, S
    [J]. PSYCHONEUROENDOCRINOLOGY, 2001, 26 (06) : 641 - 647
  • [9] A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances
    Suh, GH
    Son, HG
    Ju, YS
    Jcho, KH
    Yeon, BK
    Shin, YM
    Kee, BS
    Choi, SK
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 12 (05): : 509 - 516
  • [10] The effect of risperidone versus haloperidol on sleep patterns of schizophrenic patients - Results of a double-blind, randomised pilot trial
    Haffmans, J
    Oolders, JM
    Hoencamp, E
    Arends, JBAM
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S268 - S269